Latest News

Vitamin D a useful add-on treatment in MS

 

Highlights of the 29th Congress of the European Committee for Treatment and Research in MS (ECTRIMS), Copenhagen, DK, October 2-5, 2013 – Vitamin D supplementation for MS prophylaxis and treatment was the topic of debate at the European Charcot Foundation symposium at ECTRIMS. Speakers Dr. George Ebers, UK, and Dr. Alberto Ascherio, US, noted that numerous studies have linked low serum 25(OH)D levels with MS risk.

For example, Munger et al. reported a decreasing risk of developing MS in Caucasians for each 50 nmol/L increase in serum 25(OH)D; no association was seen for vitamin D and MS risk in blacks and Hispanics (Munger et al. JAMA 2006;296:2832-2838).

Read More

New review of PD pathophysiology

 

A new review summarizing recent data on the complex pathophysiology of PD explores the interweave of events that contribute to dopaminergic neurodegeneration (Lim & Zhang. Front Neurol 2013; epublished April 8, 2013). Read More

TOPICS:

Guidelines on managing bipolar disorder: CANMAT 2013 update

 

The Canadian Network for Mood and Anxiety Disorders (CANMAT) has produced an update of its guidelines for the management of patients with bipolar disorder (Yatham et al. Bipolar Disord 2013;15:1-44). The guidelines were produced in conjunction with the International Society for Bipolar Disorders. Read More

Optimizing treatment of RRMS: Canadian recommendations

 

SPECIAL REPORT

The Canadian MS Working Group has issued recommendations on optimizing treatment of patients with relapsing-remitting MS (Freedman et al. Can J Neurol Sci 2013;40:307-323). The publication updates recommendations published in 2004 (Freedman et al. Can J Neurol Sci 2004;31:157-168). See below for free download information. Read More